Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11591398 Single domain antibodies to programmed cell death protein 1 (PD-1)

Patent 11591398 was granted and assigned to Crescendo Biologics on February, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

The invention relates to PD-1 binding agents that block the interaction of PD-1 with its ligands, and the use of such binding agents in the treatment, prevention and detection of disease.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11591398 Single domain antibodies to programmed cell death protein 1 (PD-1)

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.